Avery Therapeutics

Jordan Lancaster, Ph.D., CEO

Oct. 10 | 10:00am | Rentschler ATMP Ballroom 

Tucson, AZ


Avery Therapeutics is a late pre-clinical stage company dedicated to improving the lives of patients with cardiovascular disease through a novel immunomodulatory biologic cell therapy platform.


By using this website you agree to accept our Privacy Policy and Terms & Conditions